Oral Administration of Zolpidem Tartrate in an Abuse-deterrent Formulation Versus an Immediate Release Formulation in Beagle Dogs
DOI:
https://doi.org/10.2340/scandjms.v1.41Keywords:
In vivo, Zolpidem, abuse-deterrent formulation, HPLCAbstract
Objective: The continuing rise of prescription drug abuse has greatly necessitated the development of an abuse-deterrent formulation. Geopolymers are a promising base for drug design as they allow for tuneable drug release and possess superior physical and chemical properties compared with conventional pharmaceutical excipients.
Methods: Geopolymer pellets containing zolpidem tartrate were administrated orally to beagle dogs as a controlled-release formulation with the commercial immediate-release product, Stilnoct® tablets, as the control.
Results: The administration of zolpidem tartrate as immediate-release tablets demonstrated an elevated immediate release plasma profile and the zolpidem tartrate in the geopolymers demonstrated a controlled-release plasma profile. The pharmacokinetic analysis demonstrated that immediate-release tablet administration generated much higher plasma concentration when compared with geopolymer pellets administration for zolpidem tartrate. On the other hand, the geopolymer formulation prolonged the time of drug release.
Conclusion: Oral administration of zolpidem tartrate in geopolymer pellets demonstrated a controlled-release plasma profile.
Downloads
References
Minozzi S, Amato L, Davoli M. Development of dependence following treatment with opioid analgesics for pain relief: a systematic review. Addiction. 2013;108(4):688–698. DOI: https://doi.org/10.1111/j.1360-0443.2012.04005.x
Epidemic: Responding to America’s Prescription Drug Abuse Crisis [Internet]. 2011. Available from: http://publications.iowa.gov/12965/1/NationalRxAbusePlan2011.pdf
Hedegaard H, Warner M, Miniño AM. Drug Overdose Deaths in the United States, 1999–2016. NCHS Data Brief. 2017;Dec(294):1–8.
Scholl L. Drug and Opioid-Involved Overdose Deaths – United States, 2013–2017. MMWR Morb Mortal Wkly Rep. 2018;67(5152):1419-1427. DOI: https://doi.org/10.15585/mmwr.mm675152e1
Assessment of Abuse Potential of Drugs – Guidance for Industry [Internet]. U.S. Food and Drug Administration. 2017. Available from: https://www.fda.gov/downloads/drugs/guidances/ucm198650.pdf
Abuse-Deterrent Opioids — Evaluation and Labeling. Guidance for Industry [Internet]. U.S. Food and Drug Administration. 2015. Available from: https://www.fda.gov/downloads/Drugs/Guidances/UCM334743.pdf
Abuse-Deterrent Opioid Analgesics [Internet]. U.S. Food and Drug Administration. 2017. Available from: https://www.fda.gov/Drugs/DrugSafety/ostmarketDrugSafetyInformationforPatientsandProviders/ucm600788.html
Bose S, Tarafder S. Calcium phosphate ceramic systems in growth factor and drug delivery for bone tissue engineering: a review. Acta Biomater. 2012;8(4):1401–1421. DOI: https://doi.org/10.1016/j.actbio.2011.11.017
Cai B, Xia W, Bredenberg S, Li H, Engqvist H. Bioceramic microneedles with flexible and self-swelling substrate. Eur J Pharm Biopharm. 2015;94:404–410. DOI: https://doi.org/10.1016/j.ejpb.2015.06.016
Cai B, Engqvist H, Bredenberg S. Evaluation of the resistance of a geopolymer-based drug delivery system to tampering. Int J Pharm. 2014;465(1–2):169–174. DOI: https://doi.org/10.1016/j.ijpharm.2014.02.029
Jämstorp E, Forsgren J, Bredenberg S, Engqvist H, Strømme M. Mechanically strong geopolymers offer new possibilities in treatment of chronic pain. J Control Release 2010;146(3):370–377. DOI: https://doi.org/10.1016/j.jconrel.2010.05.029
Ebina Y, Okada S, Hamazaki S, Midorikawa O. Liver, kidney, and central nervous system toxicity of aluminum given intraperitoneally to rats: A multiple-dose subchronic study using aluminum nitrilotriacetate. Toxicol Appl Pharmacol. 1984;75(2):211–218. DOI: https://doi.org/10.1016/0041-008X(84)90203-5
Cai B. Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Science and Technology. 2020. Available from: http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-245031
Aguilar F, Autrup H, Barlow S, Castle L, Crebelli R, Dekant W, et al. Safety of aluminium from dietary intake. Scientific Opinion of the Panel on Food Additives, Flavourings, Processing Aids and Food Contact Materials (AFC). EFSA J. 2008;6(7):1–34. DOI: https://doi.org/10.2903/j.efsa.2008.754
Simon V, Cavalu S, Prinz M, Vanea E, Neumann M, Simon S. Albumin adsorption on the surface of iron containing aluminosilicates. Eur Cells Mater. 2008;16(Suppl. 1):55.
Martin S, Derrien AC, Oudadesse H, Cathelineau G. Implantation of aluminosilicate / calcium phosphate materials’ influence on bone formation in rabbit tibias. Eur Cells Mater. 2002;9:71–72.
Forsgren J, Jämstorp E, Bredenberg S, Engqvist H, Strømme M. A ceramic drug delivery vehicle for oral administration of highly potent opioids. J Pharm Sci. 2010;99(1):219–226. DOI: https://doi.org/10.1002/jps.21814
Fentanyl citrate | C28H36N2O8 – PubChem [Internet]. Available from: https://pubchem.ncbi.nlm.nih.gov/compound/Fentanylcitrate
Zolpidem tartrate | C23H27N3O7 – PubChem [Internet]. Available from: https://pubchem.ncbi.nlm.nih.gov/compound/Zolpidemtartrate#section=Solubility
Zou H, Shimizu J, Wanke C, Iordanov VP. Transit and pH in Fasted Beagle Dogs with the IntelliCap System. 2013. Available from: https://api.semanticscholar.org/36bb5132d09eed1244e59fa8b180ed0e52b11874
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Amina Vazda, Wei Xia, Håkan Engqvist
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (https://creativecommons.org/licenses/by-nc/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
